Graduate School of Pharmaceutical Sciences, Hokkaido University
Laboratory for Bioanalysis and Molecular Imaging
Members

D3: Kazuki Terada

  • Date of Birth June 19
  • Place of Birth Himeji Hyogo

Education

  • 2014.4. - 2018.3.Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan
  • 2018.4. - presentGraduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan

Research Experience

  • 2020.4.Research Fellow, the Japan Society for the Promotion of Science (DC1, ~2023.3)

Membership of Academic Societies

Japanese Society for Molecular Imaging

Japanese Cancer Association

Honors and Awards

  • 2019.5.Best Presentation Award (14th Annual Meeting of the Japanese Society for Molecular Imaging)

Publications

  1. Nakajima K*, Miyazaki F*, Terada K, Takakura H, Suzuki M, Ogawa M. Comparison of low-molecular-weight ligand and whole antibody in prostate-specific membrane antigen targeted near-infrared photoimmunotherapy. Int J Pharm 2021, 609, 121135. *Contributed equally. PMID 34571072
  2. Terada K, Nakajima K, Takakura H, Ogawa M. Elucidation of the mechanism in photoimmunotherapy with small peptides as a targeting ligand. JSMI Report 2020, 13 (1), 23-26.

Presentations

  1. Terada K, Nakajima K, Takakura H, Ogawa M. Elucidation of the mechanism in photoimmunotherapy with RGD peptides targeting integrin alpha v beta 3. The 79th Annual Meeting of the Japanese Cancer Association, 10/1-3, OJ16-2-5, Hiroshima, Japan, Oct 1, 2020. (Oral)
  2. Miyazaki F, Nakajima K, Terada K, Takakura H, Ogawa M. Development of a new drug for photoimmunotherapy with small molecule ligand targeting PSMA. 140th　Annual Meeting of the Pharmaceutical Society of Japan, 3/25-28, 28M-pm03S, Kyoto, Japan, Mar 28, 2020. (Oral)
  3. Terada K, Nakajima K, Takakura H, Ogawa M. Development of a new agent for near-infrared photoimmunotherapy with small peptides as a targeting ligand. World Molecular Imaging Congress 2019, 9/4-7, P322, Montréal, Canada, Sep 7, 2019. (Poster)
  4. Terada K, Nakajima K, Takakura H, Ogawa M. Elucidation of the mechanism in photoimmunotherapy with small peptides as a targeting ligand. 14th Annual Meeting of the Japanese Society for Molecular Imaging, 5/23-24, PA-33, Sapporo, Japan, May 23, 2019. (Poster)
  5. Terada K, Nakajima K, Takakura H, Ogawa M. Development of a novel agent for photoimmunotherapy with small peptides as a targeting ligand. The 11th AACR-JCA Joint Conference, 2/8-12, D79, Maui, USA, Feb 12, 2019. (Poster)
  6. Terada K, Takakura H, Nakajima K, Ogawa M. Development of a new therapeutic agent for photoimmunotherapy with small peptides as a targeting ligand. The 77th Annual Meeting of the Japanese Cancer Association, 9/27-9/29, J-1023, Osaka, Japan, Sep 27, 2018. (Oral)
  7. Terada K, Takakura H, Nakajima K, Ando K, Ogawa M. Development of a new compound for photoimmunotherapy with small peptides. 13th Annual Meeting of the Japanese Society for Molecular Imaging, 5/31-6/1, PB-21, Tokyo, Japan, June 1, 2018. (Poster)